Clinical Trial Update: Cilostazol Stroke Prevention Study : A Placebo-controlled Double-blind Trial for Secondary Prevention of Cerebral Infarction. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating cilostazol for secondary prevention of cerebral infarction completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Infarction

Drugs mentioned

• Cilostazol (Cilostazol)

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Cerebral Infarction | Phase 3 | Status: COMPLETED